{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:08:37Z","timestamp":1791234517672,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10072-023-07254-1","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T16:02:20Z","timestamp":1702310540000},"page":"1399-1408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impulse control disorders in Parkinson\u2019s disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Lenise G.","family":"Soileau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norris C.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah J.","family":"Spillers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V.","family":"D\u2019antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor M.","family":"Galardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patil","family":"Shilpadevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"7254_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/bs.vh.2014.12.009","volume":"98","author":"PC McHugh","year":"2015","unstructured":"McHugh PC, Buckley DA (2015) The structure and function of the dopamine transporter and its role in CNS diseases. Vitam Horm 98:339\u2013369","journal-title":"Vitam Horm"},{"issue":"1","key":"7254_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","volume":"39","author":"MO Klein","year":"2019","unstructured":"Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG (2019) Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol 39(1):31\u201359","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"7254_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/35077500","volume":"2","author":"T Paus","year":"2001","unstructured":"Paus T (2001) Primate anterior cingulate cortex: where motor control, drive and cognition interface. Nat Rev Neurosci 2(6):417\u2013424","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"7254_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/cercor\/8.3.218","volume":"8","author":"M Luciana","year":"1998","unstructured":"Luciana M, Collins PF, Depue RA (1998) Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cereb Cortex 8(3):218\u2013226","journal-title":"Cereb Cortex"},{"key":"7254_CR5","doi-asserted-by":"crossref","unstructured":"Depue RA, Collins PF (1999) Neurobiology of the structure of personality: dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22(3):491\u2013517; discussion 518\u2013569","DOI":"10.1017\/S0140525X99002046"},{"issue":"3","key":"7254_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00213-008-1099-6","volume":"199","author":"KC Berridge","year":"2008","unstructured":"Berridge KC, Kringelbach ML (2008) Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199(3):457\u2013480","journal-title":"Psychopharmacology"},{"key":"7254_CR7","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):939\u201353"},{"key":"7254_CR8","unstructured":"Focus On Parkinson\u2019s Disease Research | National Institute of Neurological Disorders and Stroke [Internet]. [cited 2023 Oct 10]. Available from: https:\/\/www.ninds.nih.gov\/current-research\/focus-disorders\/focus-parkinsons-disease-research"},{"key":"#cr-split#-7254_CR9.1","unstructured":"Sonne J, Reddy V, Beato MR (2023) Neuroanatomy, substantia nigra. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"key":"#cr-split#-7254_CR9.2","unstructured":"[cited 2023 Jul 8]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536995\/"},{"key":"#cr-split#-7254_CR10.1","unstructured":"Sonne J, Goyal A, Lopez-Ojeda W (2023) Dopamine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"key":"#cr-split#-7254_CR10.2","unstructured":"[cited 2023 Jul 8]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535451\/"},{"key":"#cr-split#-7254_CR11.1","unstructured":"Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia AS, McNamara JO et al (2001) Circuits within the basal ganglia system. In: Neuroscience 2nd edition [Internet]. Sinauer Associates"},{"key":"#cr-split#-7254_CR11.2","unstructured":"[cited 2023 Jul 8]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK10847\/"},{"key":"7254_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA (2012) Parkinson\u2019s disease. Subcell Biochem 65:389\u2013455","journal-title":"Subcell Biochem"},{"issue":"9","key":"7254_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00702-013-0981-5","volume":"120","author":"KR Chaudhuri","year":"2013","unstructured":"Chaudhuri KR, Rizos A, Sethi KD (2013) Motor and nonmotor complications in Parkinson\u2019s disease: an argument for continuous drug delivery? J Neural Transm (Vienna) 120(9):1305\u20131320","journal-title":"J Neural Transm (Vienna)"},{"key":"7254_CR14","doi-asserted-by":"publisher","unstructured":"Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C; Movement Disorder Society Evidence-Based Medicine Committee (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord 33(8):1248\u20131266. https:\/\/doi.org\/10.1002\/mds.27372. Erratum in: Mov Disord. 2018;33(12):1992","DOI":"10.1002\/mds.27372"},{"key":"#cr-split#-7254_CR15.1","unstructured":"Choi J, Horner KA (2022) Dopamine agonists [Internet]. StatPearls [Internet]. StatPearls Publishing"},{"key":"#cr-split#-7254_CR15.2","unstructured":"[cited 2023 Mar 29]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551686\/"},{"issue":"1","key":"7254_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/endo.140.1.6437","volume":"140","author":"C Li","year":"1999","unstructured":"Li C, Chen P, Smith MS (1999) Neuropeptide Y and tuberoinfundibular dopamine activities are altered during lactation: role of prolactin. Endocrinology 140(1):118\u2013123","journal-title":"Endocrinology"},{"issue":"11","key":"7254_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2165\/00002512-200320110-00006","volume":"20","author":"R Inzelberg","year":"2003","unstructured":"Inzelberg R, Schechtman E, Nisipeanu P (2003) Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson\u2019s disease. Drugs Aging 20(11):847\u2013855","journal-title":"Drugs Aging"},{"issue":"5","key":"7254_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/biom13050829","volume":"13","author":"MM Lewis","year":"2023","unstructured":"Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J et al (2023) Dopamine D1 agonists: first potential treatment for late-stage Parkinson\u2019s disease. Biomolecules 13(5):829","journal-title":"Biomolecules"},{"issue":"8","key":"7254_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(13)70117-0","volume":"12","author":"AH Schapira","year":"2013","unstructured":"Schapira AH, McDermott MP, Barone P, Comella CL, Albrecht S, Hsu HH, Massey DH, Mizuno Y, Poewe W, Rascol O, Marek K (2013) Pramipexole in patients with early Parkinson\u2019s disease (PROUD): a randomised delayed-start trial. Lancet Neurol 12(8):747\u2013755. https:\/\/doi.org\/10.1016\/S1474-4422(13)70117-0","journal-title":"Lancet Neurol"},{"issue":"4","key":"7254_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/syn.21805","volume":"69","author":"P Seeman","year":"2015","unstructured":"Seeman P (2015) Parkinson\u2019s disease treatment may cause impulse\u2013control disorder via dopamine D3 receptors. Synapse 69(4):183\u2013189","journal-title":"Synapse"},{"issue":"2","key":"7254_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, David AS, Evans AH, Grant JE, Stacy M (2015) Clinical spectrum of impulse control disorders in Parkinson\u2019s disease. Mov Disord 30(2):121\u2013127","journal-title":"Mov Disord"},{"key":"#cr-split#-7254_CR22.1","unstructured":"Fariba KA, Gokarakonda SB (2023) Impulse control disorders. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing"},{"key":"#cr-split#-7254_CR22.2","unstructured":"[cited 2023 Oct 9]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562279\/"},{"issue":"4","key":"7254_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0025-6196(11)60538-7","volume":"84","author":"JM Bostwick","year":"2009","unstructured":"Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (2009) Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 84(4):310\u2013316","journal-title":"Mayo Clin Proc"},{"key":"7254_CR24","unstructured":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | PLOS Medicine [Internet]. [cited 2023 Oct 9]. Available from: https:\/\/journals.plos.org\/plosmedicine\/article?id=10.1371\/journal.pmed.1003583"},{"issue":"1","key":"7254_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12883-022-02830-y","volume":"22","author":"T Li","year":"2022","unstructured":"Li T, Zou S, Zhang Z, Liu M, Liang Z (2022) Efficacy of pramipexole on quality of life in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. BMC Neurol 22(1):320","journal-title":"BMC Neurol"},{"issue":"2","key":"7254_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455\u2013463","journal-title":"Biometrics"},{"issue":"8","key":"7254_CR27","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, HerranzBarcenas A, Vela L, Sanchez Alonso P et al (2014) Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 85(8):840\u2013844","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"7254_CR28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/ene.13034","volume":"23","author":"A Rizos","year":"2016","unstructured":"Rizos A, Sauerbier A, Antonini A, Weintraub D, Martinez-Martin P, Kessel B et al (2016) A European multicentre survey of impulse control behaviours in Parkinson\u2019s disease patients treated with short- and long-acting dopamine agonists. Eur J Neurol 23(8):1255\u20131261","journal-title":"Eur J Neurol"},{"key":"7254_CR29","volume":"2011","author":"S Hisahara","year":"2011","unstructured":"Hisahara S, Shimohama S (2011) Dopamine receptors and Parkinson\u2019s disease. Int J Med Chem 2011:403039","journal-title":"Int J Med Chem"},{"issue":"4","key":"7254_CR30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/bph.12988","volume":"172","author":"M Wood","year":"2015","unstructured":"Wood M, Dubois V, Scheller D, Gillard M (2015) Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. Br J Pharmacol 172(4):1124\u20131135","journal-title":"Br J Pharmacol"},{"issue":"4","key":"7254_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/syn.21805","volume":"69","author":"P Seeman","year":"2015","unstructured":"Seeman P (2015) Parkinson\u2019s disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse 69(4):183\u2013189","journal-title":"Synapse"},{"issue":"9","key":"7254_CR32","first-page":"590","volume":"40","author":"G DeMaagd","year":"2015","unstructured":"DeMaagd G, Philip A (2015) Part 2: introduction to the pharmacotherapy of Parkinson\u2019s disease, with a focus on the use of dopaminergic agents. P T 40(9):590\u2013600","journal-title":"P T"},{"issue":"Suppl","key":"7254_CR33","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.parkreldis.2007.06.002","volume":"13","author":"A Antonini","year":"2007","unstructured":"Antonini A (2007) Continuous dopaminergic stimulation\u2013from theory to clinical practice. Parkinsonism Relat Disord 13(Suppl):S24-28","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"7254_CR34","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.clinthera.2012.02.008","volume":"34","author":"JP Elshoff","year":"2012","unstructured":"Elshoff JP, Braun M, Andreas JO, Middle M, Cawello W (2012) Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies. Clin Ther 34(4):966\u2013978","journal-title":"Clin Ther"},{"issue":"1","key":"7254_CR35","first-page":"37","volume":"37","author":"M Wolfschlag","year":"2023","unstructured":"Wolfschlag M, H\u00e5kansson A (2023) Drug-induced gambling disorder: epidemiology, neurobiology, and management. Pharmaceut Med 37(1):37\u201352","journal-title":"Pharmaceut Med"},{"issue":"15","key":"7254_CR36","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25(15):2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"issue":"1","key":"7254_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","volume":"41","author":"M Grall-Bronnec","year":"2018","unstructured":"Grall-Bronnec M, Victorri-Vigneau C, Donnio Y, Leboucher J, Rousselet M, Thiabaud E et al (2018) Dopamine agonists and impulse control disorders: a complex association. Drug Saf 41(1):19\u201375","journal-title":"Drug Saf"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07254-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T07:27:34Z","timestamp":1710487654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7254"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07254-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article is based on previously conducted studies and contains no new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}